🇺🇸 FDA
Patent

US 7312227

Compositions useful as inhibitors of JAK and other protein kinases

granted A61PA61P11/00A61P11/06

Quick answer

US patent 7312227 (Compositions useful as inhibitors of JAK and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61P, A61P11/00, A61P11/06, A61P19/02, A61P21/04